Purchases and Sales Made in Q3 2023 in Moon Lake Immunotherapeutics (MLTX)
This table provides information about the institutional ownership of Moon Lake Immunotherapeutics (MLTX) during Q3 2023. The information is specifically focused on institutions that hold shares of MoonLake Immunotherapeutics.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2023
Q3 2023
|
Sectoral Asset Management Inc
Montreal, A8 |
SELL
|
- |
-86.6K- 46.93% |
$4.19M - $5.31M
|
98K
$4.21M
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-150K- 94.07% |
$7.25M - $9.19M
|
9.45K
$406K
|
|
Nov 14, 2023
Q3 2023
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-366K- 43.74% |
$17.7M - $22.4M
|
471K
$20.3M
|